Changing the Game in
Drug Development and Patient Access

Model-informed Drug Development
Health Economics/Outcomes Research & Real World Evidence
Regulatory Science, Strategy & Services

Certara Supported 90+ Percent of US FDA Novel New Drug Approvals for Fourth Consecutive Year

US FDA Awards Certara’s Simcyp Division Two New Dermal Virtual Bioequivalence Grants

Our Mission

Enable superior drug development and patient care decision-making through model-informed drug development, regulatory science, real world evidence and knowledge integration, thus optimizing R&D productivity, commercial value and patient outcomes.

Latest from Certara

Blog

In the Press

Webinars